New study: aerobic exercise and relaxation may boost recovery after prostate cancer surgery

NCT ID NCT07172854

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether adding aerobic exercise (walking on a treadmill) and relaxation training to standard pelvic floor muscle training helps men recover bladder control and sexual function after prostate cancer surgery. Forty-eight men who had nerve-sparing robotic prostatectomy within the past year will be randomly assigned to either standard care or standard care plus the extra exercises. The goal is to see if a more complete rehab program improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pelvic floor muscle training, aerobic exercise, relaxation training, and patient education
What this could lead to
If it works, this could point toward a better rehabilitation program to help men recover bladder control and sexual function after prostate cancer surgery.
What could go wrong
This is a small, early-stage trial with only 48 participants, so results may not apply to everyone. The added exercises may not provide extra benefit over standard pelvic floor training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 65 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male participants aged 40 to 65 years * Underwent nerve-sparing robotic radical prostatectomy within the past 12 months * Ability to voluntarily contract pelvic floor muscles * Cognitive capacity sufficient for cooperation with study assessments and interventions, as determined by the Montreal Cognitive Assessment (MoCA) Exclusion Criteria: * Presence of acute illness (e.g., urinary tract infection, respiratory infection, interstitial cystitis, bladder or gastrointestinal bleeding) * Within the first 3 weeks after prostatectomy surgery (acute postoperative period) * Neurological disorders or diagnosis of neurogenic bladder * Diagnosed cognitive or psychiatric disorders * Preoperative urinary incontinence or erectile dysfunction * History of prior bladder or prostate surgery before prostatectomy * Participation in pelvic floor muscle training within the last 6 months * Refusal to participate or absence of signed informed consent form

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Erectile dysfunction following radical prostatectomy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.